AI Repurposes Drugs for Severe Bacterial Infections

Researchers have employed artificial intelligence to identify existing approved drugs potentially effective against Streptococcus pneumoniae, a bacterium causing severe infections like pneumonia and meningitis. Published in Advanced Science, this AI-driven drug repurposing strategy offers a streamlined and cost-effective method. It aims to combat antimicrobial resistance, which is a growing global health concern.